Umbilical Cord Derived Mesenchymal Stem Cell (UC -MSC) Transplantation for Children Suffering From Biliary Atresia (UCMSCBA)
Evaluation Safety and Efficacy of Umbilical Cord Derived Mesenchymal Stem Cell (UC -MSC) Transplantation for Children Suffering From Liver Cirrhosis Due to Biliary Atresia: A Matched Control Prospective Study
Sponsor: Number 2 Children's Hospital, Ho Chi Minh City
This PHASE1/PHASE2 trial investigates Primary Biliary Cirrhosis and is currently completed. Number 2 Children's Hospital, Ho Chi Minh City leads this study, which shows 8 recorded versions since 2019 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE1/PHASE2
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1/PHASE2
Status: Unknown Status → Completed · Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Feb 2023 — Jul 2024 [monthly]
Unknown Status PHASE1_PHASE2
-
Nov 2022 — Feb 2023 [monthly]
Unknown Status PHASE1_PHASE2
Status: Recruiting → Unknown Status
▶ Show 3 earlier versions
-
Jan 2021 — Nov 2022 [monthly]
Recruiting PHASE1_PHASE2
-
Oct 2020 — Jan 2021 [monthly]
Recruiting PHASE1_PHASE2
Status: Not Yet Recruiting → Recruiting
-
Sep 2020 — Oct 2020 [monthly]
Not Yet Recruiting PHASE1_PHASE2
First recorded
Aug 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Number 2 Children's Hospital, Ho Chi Minh City
- Vinmec Research Institute of Stem Cell and Gene Technology
For direct contact, visit the study record on ClinicalTrials.gov .